pemetrexed,paclitaxel,cisplatin,vinorelbine,nivolumab,docetaxel,carboplatin,gemcitabine,ipilimumab
bms
['check,mate,816']
today at the 2023 annual meeting, dr claire snyder will present on digital health and the quest to improve outcomes. will. report on the checkmate 816 trial. 
Leading #cancer treatment, research and patient care. Listen to our podcasts at https://t.co/7IgfJECvU8